" class="no-js "lang="en-US"> Appointments Archives - Medtech Alert
Friday, March 31, 2023

Sort by:

Date

Top Post

Almirall Appoints Mercedes Diz as VP, Corporate Strategy

Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]

Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions

Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]

Sensorion Appoints Khalil Barrage as Interim Chairman of the Board

Sensorion, a pioneering clinical-stage biotechnology company that specializes in gene therapies in the ear, announces […]

Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors

Glyscend Therapeutics, a clinical-stage biotechnology company pioneering a new generation of orally administered polymer therapies, […]

Xeris Biopharma Appoints Ricki Fairley to Board of Directors

Xeris Biopharma, a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing […]

Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today […]

Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors

Aadi Bioscience, a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined […]

Meliora Therapeutics Appoints Claudio Chuaqui as Head of Drug Discovery

Meliora Therapeutics, a biotech company pioneering a machine learning-driven approach to mechanism-driven oncology drug development, […]

GeminiBio Strengthens Board of Directors with Addition of Bryan Poltilove

Gemini BioProducts (GeminiBio), a portfolio company of BelHealth, a Florida-based healthcare private equity firm, and […]

Celyad Oncology Appoints Georges Rawadi as Its New CEO

Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell […]

Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more